We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

ELISA Kit Accurately Detects Bioactive Hepcidin Levels

By LabMedica International staff writers
Posted on 18 Aug 2015
An enzyme-linked immunosorbent assay (ELISA) kit has been introduced that accurately detects bioactive hepcidin levels as an additional marker to aid in identifying a variety of disorders.

Hepcidin has been identified as a factor in regulating the amount of iron in humans and unbalanced iron level can lead to many common medical conditions including anemia and iron overload disease, and can occur in chronic kidney disease, inflammation, or diabetes mellitus.

Image: The DRG Hepcidin 25 HS enzyme-linked immunosorbent assay (ELISA) kit (Photo courtesy of DRG International).
Image: The DRG Hepcidin 25 HS enzyme-linked immunosorbent assay (ELISA) kit (Photo courtesy of DRG International).

The new Hepcidin 25 (bioactive) HS ELISA kit has an analytical sensitivity of 0.153 ng/mL, with a measuring range of 0 81 ng/mL to 153 ng/mL. Serum or plasma samples can be assessed and the total incubation time is less than two hours. The ELISA is user-friendly as no shaker and no assay buffer is required, and all reagents except wash solution are ready-to-use.

The new DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit is manufactured by DRG International (Springfield Township, NJ, USA) and is more sensitive that their previous product for measuring hepcidin. The DRG Hepcidin 25 (bioactive) HS ELISA Kit is available worldwide, providing a simple, fast and accurate method to test hepcidin levels. The measurement results of this kit offer more information to help treat medical issues including iron deficiency diseases, which are some of the most common diseases worldwide. The ELISA kit is Conformité Européenne (CE) marked.

Cyril E. Geacintov, PhD, founder, president and CEO of DRG International, said, “We at DRG International saw the need for an accurate and easy to use hepcidin testing kit and are encouraged by the great success that our customers have seen using the product. This kit is an important step to meet the rapidly growing worldwide interest in hepcidin testing and the applications of that testing in the health and wellness community.”

The new Hepcidin ELISA kit was showcased at the American Association for Clinical Chemistry (AACC) annual meeting held from July 27-30, 2015, in Atlanta (Georgia, USA).

Related Links:

DRG International



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test

Latest Immunology News

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients